Skip to main content

RedHill Biopharma Ltd.

corporate_fare Company Profile

RedHill Biopharma Ltd.

RDHL·NASDAQ·Life Sciences·CIK 0001553846

RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on the U.S. development and commercialization of drugs for gastrointestinal (GI) diseases, infectious diseases, and oncology. The company's main goal is to become a leading specialty biopharmaceutical company, with a current focus on advancing its pipeline of clinical-stage therapeutic candidates. RedHill Biopharma also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin), in the U.S. through a partnership with Cumberland. The company continues to explore strategic plans for other potential products and activities. RedHill Biopharma Ltd. was incorporated on August 3, 2009, as a private company limited by shares under the laws of the State of Israel. Its principal executive offices are located at 21 Ha'arba'a Street, Tel-Aviv, Israel. The company completed its initial public offering in Israel in February 2011, issuing 14,302,300 Ordinary Shares and 7,151,150 tradable Series 1 Warrants for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company listed ADSs on Nasdaq, which were subsequently listed on the Nasdaq Global Market on July 20, 2018. On February 13, 2020, its Ordinary Shares were voluntarily delisted from the Tel-Aviv Stock Exchange. On November 15, 2023, the ADSs were transferred from the Nasdaq Global Market to Nasdaq, where they are currently traded under the symbol "RDHL." The company's capital expenditures for the years ended December 31, 2025, 2024, and 2023, were approximately $4,500, $8,700, and $9,500, respectively, primarily involving basic equipment and leasehold improvements.

RedHill Biopharma Ltd. (NASDAQ:RDHL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for RDHL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-07, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 19 rated 8 or above. Recent SEC coverage for RDHL spans 6-K, 424B3, F-3, 424B5.

Recent high-impact activity:

  • RedHill Biopharma Gets 180-Day Nasdaq Extension to Regain $1.00 Bid Price
  • RedHill Reports H1 2026 Loss and Going Concern Warning Amid Portfolio Reset
  • RedHill Secures Global Rights to Rebyota and U.S. Rights to Clenpiq in $12M Upfront Deal
  • RedHill Acquires Commercialization Rights to Ferring's Rebyota and Clenpiq
  • RedHill Sells Talicia to Apotex for $18M Upfront, Unlocking Cash for Growth

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$286K
Net Income
-$429K
Diluted EPS
$0.00
Op. Cash Flow
-$9.65M
Free Cash Flow
-$9.66M
Operating Income
-$7.94M
Cash & Equivalents
$1.35M
Debt / Equity
0.00×
Net Margin
-150.0%
Shares Outstanding
50.92B sh
Source: 20-F · filed 2026-04-27 · accession 0001104659-26-049055

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 61,151 shares in RDHL as of the October 30, 2026 settlement, a 52.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 10.7% of RDHL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)61,151 shares as of October 30, 2026
Change vs prior period▼ 52.3%
Days to cover1.00 at avg daily volume of 132,590
Daily short volume (FINRA facilities)10.7% of 6,491 shares on November 20, 2026
5-day average short volume12.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for RDHL, detected from its recent SEC filings · based on capital-structure filings through 2026-10-13.

2 recent capital raisesATM program1 shelf registration

ATM Offering Expanded · Significant Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

RDHL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with R →
$0.3105 -3.96% today
52-week range · as of 2026-10-07 $0.3105 – $2.16
Market cap
$2.5M
Volume
24.3K (0.3× avg)
3-mo avg 92.5K
Live data · 2026-11-22 07:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RDHL - Latest Insights

RDHL
Oct 07, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4981
Real-time Price: $0.3105 info
Change: -$0.1876 (-38%) info
Market Cap: $2.497M info
RDHL
Sep 30, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4797
Real-time Price: $0.3105 info
Change: -$0.1692 (-35%) info
Market Cap: $2.497M info
RDHL
Sep 01, 2026, 7:10 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.9195
Real-time Price: $0.3105 info
Change: -$0.609 (-66%) info
Market Cap: $2.497M info
RDHL
Sep 01, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.9016
Real-time Price: $0.3105 info
Change: -$0.5911 (-66%) info
Market Cap: $2.497M info
RDHL
Aug 31, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.6303
Real-time Price: $0.3105 info
Change: -$0.3198 (-51%) info
Market Cap: $2.497M info
RDHL
Jul 28, 2026, 7:04 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.640
Real-time Price: $0.3105 info
Change: -$0.3295 (-51%) info
Market Cap: $2.497M info
RDHL
Jul 14, 2026, 6:00 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.690
Real-time Price: $0.3105 info
Change: -$0.3795 (-55%) info
Market Cap: $2.497M info
RDHL
Jul 02, 2026, 7:32 AM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $0.735744
Real-time Price: $0.3105 info
Change: -$0.425244 (-58%) info
Market Cap: $2.497M info
RDHL
Jun 29, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.860
Real-time Price: $0.3105 info
Change: -$0.5495 (-64%) info
Market Cap: $2.497M info
RDHL
Jun 29, 2026, 7:00 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.860
Real-time Price: $0.3105 info
Change: -$0.5495 (-64%) info
Market Cap: $2.497M info
RDHL
Jun 22, 2026, 4:21 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.8005
Real-time Price: $0.3105 info
Change: -$0.490 (-61%) info
Market Cap: $2.497M info
RDHL
Jun 22, 2026, 4:10 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.8499
Real-time Price: $0.3105 info
Change: -$0.5394 (-63%) info
Market Cap: $2.497M info
RDHL
Jun 22, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.840
Real-time Price: $0.3105 info
Change: -$0.5295 (-63%) info
Market Cap: $2.497M info
RDHL
Jun 22, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.792
Real-time Price: $0.3105 info
Change: -$0.4815 (-61%) info
Market Cap: $2.497M info
RDHL
Jun 18, 2026, 8:03 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7799
Real-time Price: $0.3105 info
Change: -$0.4694 (-60%) info
Market Cap: $2.497M info
RDHL
Jun 18, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.7839
Real-time Price: $0.3105 info
Change: -$0.4734 (-60%) info
Market Cap: $2.497M info
RDHL
Jun 09, 2026, 7:02 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $0.3105 info
Change: -$0.9852 (-76%) info
Market Cap: $2.497M info
RDHL
Jun 09, 2026, 7:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $0.3105 info
Change: -$0.9852 (-76%) info
Market Cap: $2.497M info
RDHL
Jun 08, 2026, 7:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.00
Real-time Price: $0.3105 info
Change: -$0.6895 (-69%) info
Market Cap: $2.497M info
RDHL
Jun 02, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.3105 info
Change: -$0.6995 (-69%) info
Market Cap: $2.497M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets